NexImmune, Inc. (NEXI) Financials
NEXI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 14.6 million | 6.3 million |
| 2023-06-30 | 23.5 million | 6.5 million |
| 2023-03-31 | 30.7 million | 7.1 million |
| 2022-12-31 | 43.1 million | 10.8 million |
NEXI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -7.3 million | 1.1 million |
| 2023-06-30 | -6.0 million | 991133 |
| 2023-03-31 | -12.3 million | 842446 |
| 2022-12-31 | -11.3 million | 1.5 million |
NEXI Net Income
No data available :(
NEXI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 9.0 million | - | 604638 |
| 2023-06-30 | 16.3 million | - | 749172 |
| 2023-03-31 | 22.3 million | - | 888161 |
| 2022-12-31 | 34.6 million | - | 1.0 million |
NEXI Shares Outstanding
NEXI Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 981 | 6.0 million | 4.0 million | - |
| 2023-06-30 | 5019 | 4.9 million | 2.9 million | - |
| 2023-03-31 | 42720 | 6.1 million | 3.7 million | - |
| 2022-12-31 | 223963 | 13.7 million | 3.5 million | - |
NEXI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 265542 |
| 2023-06-30 | - | 400231 |
| 2023-03-31 | - | 394506 |
| 2022-12-31 | - | 423235 |
NEXI
Price: $3.37
52 week price:
Earnings Per Share: -42.05 USD
P/E Ratio: -0.21
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 424800
Market Capitalization: 4.9 million